DuBois, S. G., Mody, R., Van Ryn, C., Naranjo, A., Kreissman, S. G., Baker, D., … Yanik, G. A. (2016). Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG). In Journal of Clinical Oncology (Vol. 34, pp. 10526–10526). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.10526

DuBois, Steven G., Rajen Mody, Collin Van Ryn, Arlene Naranjo, Susan G. Kreissman, David Baker, Marguerite T. Parisi, et al. “Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG).” In Journal of Clinical Oncology, 34:10526–10526. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.10526.

DuBois SG, Mody R, Van Ryn C, Naranjo A, Kreissman SG, Baker D, et al. Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 10526–10526.

DuBois, Steven G., et al. “Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG).” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 10526–10526. Crossref, doi:10.1200/jco.2016.34.15_suppl.10526.

DuBois SG, Mody R, Van Ryn C, Naranjo A, Kreissman SG, Baker D, Parisi MT, Shulkin BL, Maris JM, Batra V, Park JR, Matthay KK, Yanik GA. Clinical, biologic, and outcome differences according to MIBG avidity in children with neuroblastoma: A report from the Children’s Oncology Group (COG). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 10526–10526.